2025³â 01¿ù 04ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments

New solution accelerates payments to patients participating in a clinical trial, improving experience and access
´º½ºÀÏÀÚ: 2024-10-10

NEW YORK -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, announced the launch of Medidata Patient Payments, a new solution that streamlines trial-related stipends and reimbursements for patients participating in clinical research. This offering automates the payment lifecycle and addresses the longstanding challenge of compensating participants for their time, effort, and study-related expenses, while solving for growing concerns around the financial toxicity of clinical trial encounters.

Medidata Patient Payments delivers an intuitive reimbursement experience for patients, allowing them to quickly submit requests for various expenses, including travel, meals, lodging, lost wages, childcare, and mileage. Leveraging the power of the Medidata Platform, stipends are automatically triggered by study activities, such as completing a diary or assessment, offering flexibility and convenience. This integrated approach provides a smooth process, supporting quick implementation and accommodating the preferences of both patients and study sites.

“Our Patient Payments solution is a direct reflection of the commitment and passion we have to deliver an extraordinary patient experience,” said Meghan Harrington, vice president, Clinical Trial Financial Management, Medidata. “Our partnerships with Medidata’s patient and site advisory boards, coupled with the incomparable data housed within our ecosystem, provides us with a unique opportunity to modernize the financial management experience for patients.”

Patient Payments, built on the widely adopted Medidata Platform, offers seamless access via myMedidata for patients and iMedidata accounts for sponsors and sites. Unlike standalone options, it is part of a comprehensive e-clinical suite, enabling robust integration and actionable insights throughout the study lifecycle.



 Àüü´º½º¸ñ·ÏÀ¸·Î

ClinChoice Extends 13-Year Medidata Partnership with the Addition of Clinical Data Studio
Novotech Releases Report on Global Parkinson¡¯s Disease Clinical Trial Landscape
GC Aesthetics¢ç Announces Decade-Long Clinical Evaluation of PERLE¢â Breast Implants
ASTRA 1P Starts Delivering Content Across Europe
MRI-Simmons Joins Truthset Data Collective to Further Validate Data Quality
NTT DATA and Kinaxis Collaborate to Transform Supply Chain Modernization
Falcon 3: UAE¡¯s Technology Innovation Institute Launches World¡¯s Most Powerful Small AI Models

 

Power Integrations Targets 800 V Automotive Applications with New Wide...
Synopsys and SiMa.ai Announced Strategic Collaboration to Accelerate D...
NetApp¡¯s 2024 Data Complexity Report Reveals AI¡¯s Make or Break Year...
Kirin¡¯s Electric Salt Spoon Shines At CES Innovation Awards 2025
SES¡¯s Seventh and Eighth O3b mPOWER Satellites Successfully Launched,...
Novotech Publishes Report on the Global COVID-19 Clinical Trial Landsc...
Biocodex Strengthens Supply Chain Resilience with Kinaxis

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..